Patent Assignment
Reel/Frame 061661/0035
Confirmatory License
Recorded: 2022-10-12
Pages: 2
Assignor
FRED HUTCHINSON CANCER RESEARCH CENTER
Executed: 2021-01-28
Assignee
NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
NIH DIVISION OF EXTRAMURAL INVENTIONS AND TECHNOLOGY RESOURCES (DEITR), 6705 ROCKLEDGE DRIVE, SUITE 310, MSC 7980, BETHESDA, MARYLAND, 20892-7980
Covered Property
(1)
Bispecific Affinity Reagent and Related Methods for Pretargeted Radioimmunotherapy Against CD45+ Cells
Application:
17/260,205 →
Publication:
US 2021/0269526
Related Assignments
(2)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Aug 25, 2021
From: OROZCO, JOHNNIE J.
To: FRED HUTCHINSON CANCER RESEARCH CENTER
Reel/Frame 057289/0972 →
Merger and Change of Name
Jun 8, 2022
From: FRED HUTCHINSON CANCER RESEARCH CENTER; SEATTLE CANCER CARE ALLIANCE
To: FRED HUTCHINSON CANCER CENTER
Reel/Frame 060838/0852 →